Diabetes & Endocrinology
AAV vector gene therapy, now in phase 1/2 trials, targets methylmalonic acidemia.
Glucagon antagonist promotes β-cell survival, supports new direction in basic research.
Unexpectedly low levels could mask heart failure risk.
First-of-its-kind imaging database is practical, comprehensive and open source.
Physicians are implementing an old gold standard to free up ICU beds during the pandemic.
Burosumab may enable near-normal lives for children with XLH.
Experts test intervention to improve sleep habits in pediatric patients with T1D.
1 / 5
Join our experts as they share their latest discoveries in endocrinology research, plus clinical studies and translational initiatives.
Nationwide network to expand understanding beyond T1D and T2D.
Differentiated therapies for a nuanced disease.